BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6707886)

  • 1. Nonlinear bioavailability of metoclopramide in the rat: evidence for saturable first-pass metabolism.
    Kapil RP; Axelson JE; Ongley R; Price JD
    J Pharm Sci; 1984 Feb; 73(2):215-8. PubMed ID: 6707886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo assessment of hepatic and extrahepatic metabolism of diazepam in the rat.
    Igari Y; Sugiyama Y; Sawada Y; Iga T; Hanano M
    J Pharm Sci; 1984 Jun; 73(6):826-8. PubMed ID: 6737272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of metoclopramide in rats with experimental renal and hepatic dysfunction.
    Tam YK; Axelson JE; McErlane B; Kapil RP; Riggs KW; Ongley R; Price JD
    J Pharmacol Exp Ther; 1981 Oct; 219(1):141-6. PubMed ID: 7288603
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical pharmacokinetics of metoclopramide.
    Bateman DN
    Clin Pharmacokinet; 1983; 8(6):523-9. PubMed ID: 6360466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High body clearance and low oral bioavailability of alantolactone, isolated from Inula helenium, in rats: extensive hepatic metabolism and low stability in gastrointestinal fluids.
    Lee JY; Kim SB; Chun J; Song KH; Kim YS; Chung SJ; Cho HJ; Yoon IS; Kim DD
    Biopharm Drug Dispos; 2016 Apr; 37(3):156-67. PubMed ID: 26861967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-pass metabolism of omeprazole in rats.
    Watanabe K; Furuno K; Eto K; Oishi R; Gomita Y
    J Pharm Sci; 1994 Aug; 83(8):1131-4. PubMed ID: 7983597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurement of microsomal function in hepatectomized rat].
    Ishikawa A; Tanaka E; Tsuji K; Fukao K; Misawa S; Iwasaki Y
    Nihon Geka Gakkai Zasshi; 1987 Mar; 88(3):303-7. PubMed ID: 3600583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonlinear first-pass metabolism of propranolol in the rat.
    Suzuki T; Ohkuma T; Isozaki S
    J Pharmacobiodyn; 1981 Feb; 4(2):131-41. PubMed ID: 7277199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of single doses of metoclopramide in renal failure.
    Bateman DN; Gokal R; Dodd TR; Blain PG
    Eur J Clin Pharmacol; 1981; 19(6):437-41. PubMed ID: 7250177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent pharmacokinetics of telithromycin after intravenous and oral administration to rats: contribution of intestinal first-pass effect to low bioavailability.
    Lee JH; Lee MG
    J Pharm Pharm Sci; 2007; 10(1):37-50. PubMed ID: 17498392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of metoclopramide in man with observations in the dog.
    Bateman DN; Kahn C; Davies DS
    Br J Clin Pharmacol; 1980 Apr; 9(4):371-7. PubMed ID: 7378253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 14C-Propoxyphene demethylation in the rat. An example of differences between liver and intestinal drug-presystemic metabolism.
    Horsmans Y; Saliez A; van den Berge V; Desager JP; Geubel AP; Pauwels S; Lambotte L
    Drug Metab Dispos; 1997 Nov; 25(11):1257-9. PubMed ID: 9351901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of diazepam in the rat: influence of an experimentally induced hepatic injury.
    Diaz-Garcia JM; Oliver-Botana J; Fos Galve D
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():94-101. PubMed ID: 1820943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
    Prueksaritanont T; Gorham LM; Ellis JD; Fernandez-Metzler C; Deluna P; Gehret JR; Strong KL; Hochman JH; Askew BC; Duggan ME; Gilbert JD; Lin JH; Vyas KP
    Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent presystemic elimination of propranolol due to hepatic first-pass metabolism in rats.
    Iwamoto K; Watanabe J
    J Pharm Pharmacol; 1985 Nov; 37(11):826-8. PubMed ID: 2867168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-pass metabolism of 5-fluorouracil in rats.
    Yuasa H; Gu J; Hayashi Y; Watanabe J
    J Pharm Pharmacol; 1998 Sep; 50(9):1019-25. PubMed ID: 9811163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of 4-methylumbelliferone in rats: influence of dose on its first-pass hepatic elimination.
    Morita K; Sugiyama Y; Hanano M
    J Pharmacobiodyn; 1986 Feb; 9(2):117-24. PubMed ID: 3712212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute bioavailability of metoclopramide given orally or by enema in patients with normal liver function or with cirrhosis of the liver.
    Hellstern A; Hellenbrecht D; Saller R; Gatzen M; Manus B; Achtert G; Brockmann P; Hausleiter HJ; Leuschner U
    Arzneimittelforschung; 1987 Jun; 37(6):733-6. PubMed ID: 3663273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.
    Graffner C; Lagerström PO; Lundborg P; Rönn O
    Br J Clin Pharmacol; 1979 Nov; 8(5):469-74. PubMed ID: 508553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.